arrow
Back
L

Lucas Moreno

Hospital Universitari Vall d'Hebron

31H-index
201Paper Count
2.8KCitation Count
Published Papers 55
Publication Date
Eligibility criteria in pediatric oncology Phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium
err2026-05-25
err0
PREAI
errUri Ilan; Alba Rubio-San-Simón; Natasha van Eijkelenburg; Cormac Owens; Aviva Kraus; Lucas Moreno; Fernando Carceller; Carole Lecinse; Leona Knox; Nicole Scobie; Birgit Geoerger; C. Michel Zwaan; Pamela Kearns; Francisco Bautista
errShare
errSave
Induction Regimens in High-Risk Neuroblastoma: Systematic Review of Response Rates and Toxicities
err2025-11-23
err0
errOAAI
errMartin, Samantha D.; Robinson, Eva C.; Weller, Edie; Bagatell, Rochelle; Moreno, Lucas; Dubois, Steven G.
errShare
errSave
Paediatric Strategy Forum for Medicinal Product Development of Agents Targeting GD2 Ganglioside in Children and Adolescents with Cancer
err2025-11-05
err0
errOAAI
errSteven G. DuBois; Lucas Moreno; Rochelle Bagatell; Nai-Kong Cheung; Juliet C. Gray; Franco Locatelli; C. Patrick Reynolds; Claudia Rossig; Paul M. Sondel; Nicole Drezner; Olga Kholmanshikh; Nicholas Bird; Lorna Day; Donna Ludwinski; Nicole Scobie; Vanessa Pons Sanz; Simon Ball; Bonnie Hammer; Ignacio Alvarez Rojo; Danelle Meager; Joen Sveistrup; Pablo Berlanga; Michela Casanova; Julia Glade-Bender; Margaret Macy; Daniel A. Morgenstern; Cormac Owens; Brenda J. Weigel; Alberto Pappo; Karsten Nysom; John Anderson; Franca Ligas; Giovanni Lesa; Martha Donoghue; Dominik Karres; Gilles Vassal
errShare
errSave
Recommended phase 2 dose for abemaciclib in combination with irinotecan and temozolomide in pediatric and young adult patients with relapsed/ refractory solid tumors: Results from JPCS study (Part A)
err2025-11-01
err0
errOAAI
errRibelles, Antonio Juan; Moreno, Lucas; Ogawa, Chitose; Thorwarth, Anne; Ruggiero, Antonio; Pitou, Celine; Zhou, Yanhong; Hardebeck, Molly C.; Knoderer, Holly; Lassaletta, Alvaro
errShare
errSave
Southern European Prospective Investigation Into Childhood Cancer and Nutrition (EPICkids): Study design and protocol
err2025-09-05
err0
errOAAI
errPerganti, Foteini; Huybrechts, Inge; Balduzzi, Adriana Cristina; Barr, Ronald; Biondi, Andrea; Blade, Aina Llenas; Munoz Bravo, Evangelina; Damasco, Erika; Katsagoni, Christina N.; Kattamis, Antonis; Lassaletta, Alvaro; Llopis Lera, Marta; Llort, Anna; Blanco Lopez, Jessica; Perez Martinez, Antonio; Massimino, Maura; Morales La Madrid, Andres; Moreno, Lucas; Munoz Alonso, Ana; Nicolas, Genevieve; Preziati, Giorgia; Rizzari, Sofia; Della Valle, Serena; Marquez Vega, Catalina; Walters, Michelle; Kozlakidis, Zisis; Ladas, Elena J.
errShare
errSave
Implementation of the precision oncology program in catalonia’s public health system: results, lessons learned, and future prospects
err2025-09-03
err0
errOAAI
errPilar Mur; Anna Pozuelo; Josep Tabernero; Joan Albanell; Beatriz Bellosillo; Francesc Bosch; Javier Briones; Joan Brunet; Dolors Colomer; Montserrat Domènech; Joan Manel Fontanet; Xavier Matias-Guiu; Ramon Salazar; Rosa Maria Vivanco-Hidalgo; Meritxell Mollà; Lucas Moreno; Aleix Prat; Josep Maria Ribera; Ramón Clèries; Alex Guarga; Josep A. Espinàs; Josep Maria Borras
errShare
errSave
International neuroblastoma risk group consortium: a model of networking for rare cancers
err2025-08-25
err0
errOAAI
errSusan L Cohn, MD; Wendy B London, PhD; Gudrun Schleiermacher, MD, PhD; Lucas Moreno, MD, PhD; Inge M Ambros, PhD; Peter F Ambros, PhD; Rochelle Bagatell, MD; Maja Beck Popovic, MD; Klaus Hermann Beiske, MD, PhD; Frank Berthold, MD; Suzi Birz, MScMI; Hervé J Brisse, MD; Garrett M Brodeur, MD; Penelope R Brock, MD; Susan Burchill, PhD; Angelika Eggert, MD; Sara M Federico, MD; Matthias Fischer, PhD; Brian T Furner, MS; Barbara Hero, MD; David Machin, PhD; Takehiko Kamijo, MD; Katherine K Matthay, MD; Akira Nakagawara, MD, PhD; Arlene Naranjo, PhD; Ulrike Pötschger, PhD; Dominique Valteau-Couanet, MD; Michael T Watkins, PhD; Meredith S Irwin, MD; Samuel L Volchenboum, MD, PhD; Julie R Park, MD; Andrew D J Pearson, MD; null
errShare
errSave
Management and outcome of children with high-risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease (Feb, 10.1007/s12094-025-03853-w, 2025)
err2025-04-09
err0
errOAAI
errde las Heras, Blanca Martinez; Rubio-Aparicio, Pedro M.; Rubio-San-Simon, Alba; Moreno, Lucas; Mazorra, Paula; Almaraz, Ricardo Lopez; Lopez, Mercedes Llempen; Guill, Julia Balaguer; Segura, Vanessa; Bermudez, Mar; Jimenez, Irene; Ramal, Desiree; Canete, Adela
errShare
errSave
A comprehensive clinico-pathological review of a series of pediatric, adolescents and young adults with high-grade osteosarcoma: from clinics to biomarker discovery
err2025-04-08
err0
PREAI
errBuendia-Lopez, Susana; Rubio-San-Simon, Alba; Wu, Jen-Hao; Azorin-Cuadrillero, Daniel; Sanz-Miguel, Ana; Lassaletta, Alvaro; Sirvent-Cerda, Sara Inmaculada; Rey-Portela, Laura; Abril, Juan Carlos; Moreno, Lucas; Madero-Lopez, Luis; Garcia-Castro, Javier; Bautista, Francisco
errShare
errSave
Advances in the approaches used to repurpose drugs for neuroblastoma
err2024-09-11
err0
PREAI
errMiera-Maluenda, Marta; Perez-Torres, Maria; Manas, Adriana; Rubio-San-Simon, Alba; Butjosa-Espin, Maria; Ruiz-Duran, Paula; Seoane, Jose A.; Moreno, Lucas; Segura, Miguel F.
errShare
errSave
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma
err2024-04-05
err2
errOAAI
errGallo-Oller, Gabriel; Pons, Guillem; Sansa-Girona, Julia; Navarro, Natalia; Zarzosa, Patricia; Garcia-Gilabert, Lia; Cabre-Fernandez, Paula; Burrieza, Gabriela Guillen; Valero-Arrese, Lorena; Segura, Miguel F.; Lizcano, Jose M.; de Toledo, Jose Sanchez; Moreno, Lucas; Gallego, Soledad; Roma, Josep
errShare
errSave
Combined inhibition of MDM2 and PARP lead to a synergistic anti-tumoral response in p53 wild-type rhabdomyosarcoma
err2024-03-22
err0
PREAI
errPons, Guillem; Gallo-Oller, Gabriel; Garcia-Gilabert, Lia; Zarzosa, Patricia; Sansa-Girona, Julia; Navarro, Natalia; Cabre-Fernandez, Paula; Segura, Miguel F.; De Toledo, Josep Sanchez; Gallego, Soledad; Moreno, Lucas; Roma, Josep
errShare
errSave
Epigenetic therapies for neuroblastoma: immunogenicity awakens
err2023-03-08
err3
errOAAI
errJimenez, Carlos; Moreno, Lucas; Segura, Miguel F.
errShare
errSave
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders
err2022-11-29
err6
PREAI
errCarrasco, Estela; Lopez-Fernandez, Adria; Codina-Sola, Marta; Valenzuela, Irene; Cueto-Gonzalez, Am; Villacampa, Guillermo; Navarro, Victor; Torres-Esquius, Sara; Palau, Dolors; Cruellas, Mara; Torres, Maite; Perez-Duenas, Belen; Abuli, Anna; Diez, Orland; Sabado-Alvarez, Constantino; Garcia-Arumi, Elena; Tizzano, Eduardo F.; Moreno, Lucas; Balmana, Judith
errShare
errSave
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma
err2022-10-11
err7
errOAAI
errNavarro, Natalia; Molist, Carla; Sansa-Girona, Julia; Zarzosa, Patricia; Gallo-Oller, Gabriel; Pons, Guillem; Magdaleno, Ainara; Guillen, Gabriela; Hladun, Raquel; Garrido, Marta; Segura, Miguel F.; Hontecillas-Prieto, Lourdes; de Alava, Enrique; Ponsati, Berta; Fernandez-Carneado, Jimena; Almazan-Moga, Ana; Valles-Miret, Mariona; Farrera-Sinfreu, Josep; Sanchez de Toledo, Josep; Moreno, Lucas; Gallego, Soledad; Roma, Josep
errShare
errSave
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting
errCANCER
IF5.1
err2022-09-13
err5
errOAAI
errPark, Julie R.; Villablanca, Judith G.; Hero, Barbara; Kushner, Brian H.; Wheatley, Keith; Beiske, Klaus H.; Ladenstein, Ruth L.; Baruchel, Sylvain; Macy, Margaret E.; Moreno, Lucas; Seibel, Nita L.; Pearson, Andrew D.; Matthay, Katherine K.; Valteau-Couanet, Dominique
errShare
errSave
Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program
err2022-09-03
err8
errOAAI
errJimenez, Carlos; Antonelli, Roberta; Nadal-Ribelles, Mariona; Devis-Jauregui, Laura; Latorre, Pablo; Sole, Carme; Masanas, Marc; Molero-Valenzuela, Adria; Soriano, Aroa; de Toledo, Josep Sanchez; Llobet-Navas, David; Roma, Josep; Posas, Francesc; de Nadal, Eulalia; Gallego, Soledad; Moreno, Lucas; Segura, Miguel F.
errShare
errSave
Methodological advances in the discovery of novel neuroblastoma therapeutics
err2021-11-22
err10
PREAI
errSegura, Miguel F.; Soriano, Aroa; Roma, Josep; Piskareva, Olga; Jimenez, Carlos; Boloix, Ariadna; Fletcher, Jamie, I; Haber, Michelle; Gray, Juliet C.; Cerda-Alberich, Leonor; Martinez de Las Heras, Blanca; Canete, Adela; Gallego, Soledad; Moreno, Lucas
errShare
errSave
The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models
err2021-10-14
err8
errOAAI
errMasanas, Marc; Masia, Nuria; Suarez-Cabrera, Leticia; Olivan, Mireia; Soriano, Aroa; Majem, Blanca; Devis-Jauregui, Laura; Burgos-Panadero, Rebeca; Jimenez, Carlos; Rodriguez-Sodupe, Pau; Boloix, Ariadna; Toledano, Ignasi; Guillen, Gabriela; Navarro, Alexandra; Llobet-Navas, David; Villanueva, Alberto; Sanchez de Toledo, Josep; Roma, Josep; Noguera, Rosa; Moreno, Lucas; Krauss, Rolf; Gallego, Soledad; Santamaria, Anna; Segura, Miguel F.
errShare
errSave
Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role
err2021-08-18
err15
errOAAI
errGiralt, Irina; Gallo-Oller, Gabriel; Navarro, Natalia; Zarzosa, Patricia; Pons, Guillem; Magdaleno, Ainara; Segura, Miguel F.; Sanchez de Toledo, Jose; Moreno, Lucas; Gallego, Soledad; Roma, Josep
errShare
errSave